Agios Pharmaceuticals Ownership | Who Owns Agios Pharmaceuticals?
Agios Pharmaceuticals Ownership Summary
Agios Pharmaceuticals is owned by 106.42% institutional investors, 1.68% insiders. Farallon capital management is the largest institutional shareholder, holding 9.96% of AGIO shares. BB Biotech AG Ord is the top mutual fund, with 6.16% of its assets in Agios Pharmaceuticals shares.
AGIO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Agios Pharmaceuticals | 106.42% | 1.68% | -8.11% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Farallon capital management | 5.77M | 9.96% | $191.83M |
| Vanguard group | 5.63M | 9.89% | $185.05M |
| Blackrock | 4.86M | 8.55% | $209.52M |
| Blackrock funding, inc. /de | 4.83M | 8.34% | $160.77M |
| Bellevue group | 3.59M | 6.20% | $119.41M |
| Price t rowe associates inc /md/ | 2.42M | 4.26% | $79.64M |
| State street | 2.15M | 3.78% | $70.72M |
| Macquarie group | 1.68M | 2.96% | $55.37M |
| Geode capital management | 1.35M | 2.37% | $44.36M |
| Dimensional fund advisors lp | 1.33M | 2.33% | $43.67M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Caligan partners lp | 626.28K | 5.21% | $20.58M |
| Cutter capital management, lp | 301.62K | 4.06% | $9.91M |
| Eagle health investments lp | 330.83K | 2.67% | $10.87M |
| Tcg crossover management | 697.00K | 2.65% | $23.18M |
| Bellevue group | 3.59M | 2.63% | $119.41M |
| Rock springs capital management lp | 989.75K | 2.05% | $32.92M |
| Palo alto investors lp | 268.78K | 1.90% | $8.94M |
| Frazier life sciences management | 1.28M | 1.70% | $42.56M |
| Patient square capital lp | 139.73K | 1.68% | $4.65M |
| Highvista strategies | 70.13K | 0.86% | $2.33M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tcg crossover management | 697.00K | 2.65% | 697.00K |
| Rock springs capital management lp | 989.75K | 2.05% | 647.57K |
| Deutsche bank ag\ | 935.25K | 0.01% | 265.64K |
| Orbimed advisors | 557.90K | 0.46% | 232.40K |
| Frazier life sciences management | 1.28M | 1.70% | 209.90K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jefferies financial group | - | - | -1.50M |
| Bvf inc/il | - | - | -1.07M |
| Polar capital | - | - | -1.00M |
| T. rowe price investment management | - | - | -928.60K |
| Armistice capital | 1.17M | 0.67% | -880.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Tcg crossover management | 697.00K | 2.65% | 697.00K | $23.18M |
| Baker bros. advisors lp | 189.87K | 0.06% | 189.87K | $6.31M |
| Norges bank | 145.09K | 0.00% | 145.09K | $4.77M |
| Gts securities | 22.80K | 0.00% | 22.80K | $983.14K |
| Savvy advisors | 21.78K | 0.05% | 21.78K | $724.44K |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -1.00 |
| Global financial private client | -3.00 |
| Ifp advisors | -3.00 |
| Southstate | -4.00 |
| Nelson, van denburg & campbell wealth management group | -11.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 217 | -3.56% | 61,654,515 | 3.33% | 106 | 0.99% | 108 | -5.26% | 76 | 5.56% |
| Mar 31, 2025 | 223 | -4.29% | 59,949,912 | 0.23% | 104 | 0.95% | 113 | -12.40% | 71 | 2.90% |
| Dec 31, 2024 | 231 | 4.05% | 58,738,591 | 1.40% | 103 | 1.00% | 126 | 22.33% | 70 | 2.94% |
| Sep 30, 2024 | 222 | 1.83% | 57,925,704 | 3.66% | 101 | 1.05% | 104 | 1.96% | 66 | -15.38% |
| Jun 30, 2024 | 218 | 9.00% | 55,883,066 | -6.01% | 98 | 0.88% | 102 | -0.97% | 78 | 39.29% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BB Biotech AG Ord | 3.52M | 6.16% | -220.76K |
| Vanguard US Total Market Shares ETF | 1.79M | 3.12% | 2.35K |
| Vanguard Total Stock Mkt Idx Inv | 1.81M | 3.11% | -38.53K |
| Macquarie Small Cap Core I | 1.54M | 2.65% | - |
| Delaware Small Cap Core I | 1.38M | 2.42% | -8.55K |
| Vanguard Small Cap Index | 1.41M | 2.42% | -9.02K |
| iShares Russell 2000 ETF | 1.33M | 2.29% | -25.30K |
| Polar Capital Biotech S Inc | 1.00M | 1.73% | - |
| T. Rowe Price Health Sciences | 990.65K | 1.71% | -37.30K |
| DWS Vermögensbildungsfonds I LD | 805.52K | 1.39% | 3.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 05, 2025 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | $315.09K |
| Aug 27, 2025 | Scadden David | - | Sell | $8.00K |
| Aug 08, 2025 | Goff Brian | Chief Executive Officer | Sell | $406.49K |
| Jul 10, 2025 | Scadden David | - | Sell | $56.00K |
| Jul 09, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | $419.77K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 6 |
| 2025 Q2 | - | 7 |
| 2025 Q1 | - | 16 |
| 2024 Q4 | - | 9 |
| 2024 Q3 | - | 3 |
AGIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools